Theme: Systems and Synthetic Biology: Meeting the Needs of a Changing World

Systems and Synthetic Biology 2017

Systems and Synthetic Biology 2017

About Conference

Conference Series LLC International Conferences invites all the participants from all over the world to attend "3rd International Conference on Systems and Synthetic Biology" during July 20-21, 2017 at Munich, Germany, which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Systems and Synthetic Biology is a relatively new field in biomedical research. It focuses on engineering new or modified signaling proteins to create desired signaling pathways in the cell. Every living cell is an extremely complex machine expressing thousands of different proteins. Due to superb regulation, many cells, such as photoreceptors and other neurons in vertebrates, can live for decades. Cells can also self-reproduce by division, where both daughter cells are perfectly viable. Natural selection (the “blind watchmaker”, to use Dawkins’ expression) spent hundreds of millions of year to achieve this perfection. Due to elucidation of the intricacies of cellular regulatory mechanisms we can now play evolution on our time scale: re-design proteins and signaling pathways to achieve our ends.

Systems and Synthetic Biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. It’s a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global systems and synthetic Biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period

Objective

Systems and Synthetic Biology 2017 has the goal to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. International Conference on Systems and Synthetic Biology 2017 will have an anticipated participation of 150+ delegates across the world to discuss the conference goal.

About Organizers

Conference Series LLC International is one of the leading Open Access publishers and organizers of international scientific conferences and events every year across USA, Europe & Asia  Conference Series LLC  has so far organized 300+ International Conferences across the World with 500+ peer-reviewed open access journals in basic science, health, and technology. Conference Series LLC International is also in association with more than 1000 International scientific and technological societies and associations and a team of 30,000 eminent scholars, reputed scientists as editorial board members.

Scientific Sessions

Systems and Synthetic Biology-2017 will encompass recent researches and findings in engineering new or modified signaling proteins to create desired signaling pathways in the cell. Due to superb regulation, many cells, such as photoreceptors and other neurons in vertebrates, can live for decades. Cells can also self-reproduce by division, where both daughter cells are perfectly viable. Natural selection (the “blind watchmaker”, to use Dawkins’ expression) spent hundreds of millions of year to achieve this perfection. Due to elucidation of the intricacies of cellular regulatory mechanisms we can now play evolution on our time scale: re-design proteins and signaling pathways to achieve our ends.

Systems and Synthetic Biology-2017 will be a great platform for research scientists and young researchers to share their current findings in this field of applied science. The major scientific sessions in Systems and Synthetic Biology-2017 will focus on the latest and exciting innovations in prominent areas of Systems biology and Synthetic biology research.





Market Analysis

About Systems and Synthetic Biology 2017

Systems and Synthetic Biology is all about increased genome sequencing efforts have ushered in a new era of systems biology, in which entire cellular networks are analyzed and optimized for application in the development of strains and Bioprocesses. The properties of these complex cellular networks cannot be understood by monitoring individual components alone, but from the integration of non-linear gene, protein, and metabolite interactions across multiple metabolic and regulatory networks via computer simulation.

"Synthetic biology is an emerging area of research that can broadly be described as the design and construction of novel artificial biological pathways, organisms or devices, or the redesign of existing natural biological systems."

The demand for synthetic biology is likely to increase owing to the increasing R&D expenditure in pharmaceutical and biotechnology companies, growing demand for synthetic genes, rising production of genetically modified crops, and incessantly rising funding in the field of synthetic biology. Furthermore, rising concerns over fuel consumption and increasing demand for protein therapeutics are likely to create opportunities for the synthetic biology market. However, standardization and integration of biological parts at system-level still remains a challenge for the market. Synthetic Biology mainly focusses on the Universities, Institutes and major Societies along with the latest trends in the market of Systems and Synthetic Biology.

We are delighted to invite you all to attend and register for the “3rd International Conference on Systems and Synthetic Biology (Systems and Synthetic Biology 2017)” which is going to be held during July20-21, 2017 Munich, Germany.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Systems abd Synthetic Biology 2017, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Systems and Synthetic Biology 2017 organizing committee look forward to meeting you in Germany.

For more details please visit- http://syntheticbiology.conferenceseries.com/

Importance & Scope:

Synthetic Biology 2017 is a relatively new field in biomedical research. It focuses on engineering new or modified signaling proteins to create desired signaling pathways in the cell.

Every living cell is an extremely complex machine expressing thousands of different proteins. Due to superb regulation, many cells, such as photoreceptors and other neurons in vertebrates, can live for decades. Cells can also self-reproduce by division, where both daughter cells are perfectly viable. Natural selection (the “blind watchmaker”, to use Dawkins’ expression) spent hundreds of millions of year to achieve this perfection. Due to elucidation of the intricacies of cellular regulatory mechanisms we can now play evolution on our time scale: re-design proteins and signaling pathways to achieve our ends.

Scientifically, the success of these endeavors is the ultimate proof that we know enough about cellular signaling pathways to harness them for our purposes. From a practical standpoint, targeted regulation of cell signaling paves the way to real cures of many disorders, genetic and acquired, where before we could only manage the symptoms using small molecules.

Why Munich?

Munich is the capital and largest city of the German state of Bavaria, on the banks of River Isar north of the Bavarian Alps. Munich is the third largest city in Germany, after Berlin and Hamburg, and the 12th biggest city of the European Union, with a population of above 1.5 million. The Munich Metropolitan Region is home to 5.8 million people. The city is a major center of art, advanced technologies, finance, publishing, culture, innovation, education, business, and tourism in Germany and Europe and enjoys a very high standard and quality of living, reaching #1 in Germany and #4 worldwide according to the 2015 Mercer survey. According to the Globalization and World Rankings Research Institute Munich is considered an alpha-world city, as of 2015. Munich is home to many national and international authorities, major universities, major museums and theaters. Its numerous architectural attractions, international sports events, exhibitions, conferences and Oktoberfest attract considerable tourism. Munich is one of the most prosperous and fastest growing cities in Germany.

Systems and Synthetic Biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. It’s a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global systems and synthetic Biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period

Conference Highlights:

Why to attend???

Meet the eminent researchers working in the allied areas of Systems Biology and Synthetic Biology. This conference will be the best platform to explore your research work and innovations in the respective areas. This conference is focusing on all the major fields of Synthetic Biology.

With members from around the world focused on learning about systems and synthetic biology, this is your single best opportunity to reach the largest assemblage of participants from various communities. Conduct demonstrations, distribute information, meet with current and potential speakers and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in sstems and synthetic biology fields are hallmarks of this conference.

Major Synthetic Biology Associations around the Globe

The International Association Synthetic Biology (IASB)

Synthetic Biology Organization

Industry Association of Synthetic Biology (IASB)

The Helmholtz Association, Germany

Association of Synthetic Biology Brawijaya University

Society for Biological Engineers (SBE)           

ISEE – International Society for Environmental Ethics

MIT Synthetic Biology Center

American Chemical Society

Biotechnology industrial organization

International Council for the Life Sciences

Synthetic Biology Engineering Research Center

University of Minnesota Synthetic Biology Society

Queen's Synthetic Biology Organization (QSYNBIO)

Synthetic Biology Industry Association

New York synthetic biology association – GuideStar

Target Audience:

Academicians, Scientists & Business delegates, Experts, Departmental Managers, Vice Presidents/ Directors & Brand Manufacturers/ Marketers of Consumer Products. Solution Providers (digital and mobile technology), Professors and Students from Academia in the study of Synthetic Biology & Technology.

Target Audience:

Academia      60%

Industry        30%

Others           10%

Glance at Market of Advertising and Marketing:

This report studies the global synthetic biology market for the forecast period of 2013 to 2018. This market is expected to reach $5,630.4 million by 2018 from $1,923.1 million in 2013, growing at a CAGR of 24% during the forecast period.

The global synthetic biology market is segmented on the basis of tools, technologies, applications, and geographies.

On the basis of tools, the synthetic biology market is categorized into Xeno-nucleic acids, chassis organisms, oligonucleotides, enzymes, and cloning and assembly kits. The oligonucleotides segment accounted for a major share of the synthetic biology market, by tool, in 2013.

On the basis of technologies, the synthetic biology market is segmented into enabled and enabling technologies. Enabling technologies accounted for a major share of the synthetic biology market in 2013. On the basis of applications, the synthetic biology market is segmented into environmental, medical, and industrial applications. The medical applications segment accounted for a major share of the synthetic biology market in 2013.





Sessions or Tracks

Sessions/Tracks

Conferences Series LLC invites all the participants from all over the world to attend 2nd International Conference on Systems and Synthetic Biology July 20-21, 2017 Munich, Germany which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

 

Systems and Synthetic Biology

Systems and Synthetic Biology is a relatively new field in biomedical research. It focuses on engineering new or modified signaling proteins to create desired signaling pathways in the cell. Every living cell is an extremely complex machine expressing thousands of different proteins. Due to superb regulation, many cells, such as photoreceptors and other neurons in vertebrates, can live for decades. Cells can also self-reproduce by division, where both daughter cells are perfectly viable. Natural selection (the “blind watchmaker”, to use Dawkins’ expression) spent hundreds of millions of year to achieve this perfection. Due to elucidation of the intricacies of cellular regulatory mechanisms we can now play evolution on our time scale: re-design proteins and signaling pathways to achieve our ends.

Related Conferences:

15th World Congress on Biotechnology and Biotech Industries Meet ,Rome, Italy, March 20-21, 2017;  6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orlando, USA, March 20-22, 2017;  14th Asia-Pacific Biotech Congress, Beijing, China, April 10-12, 2017;  5th International Conference on Integrative Biology, London, UK, June 19-21, 2017.

 

Synthetic Genomics

Synthetic genomics is an early field of engineered science that uses parts of hereditary alteration on prior life frames with the plan of delivering some item or wanted conduct with respect to the living thing so made. Synthetic genomics joins strategies for the fake amalgamation of DNA with computational methods to plan it. These strategies permit researchers and specialists to build hereditary material that would be inconceivable or illogical to deliver utilizing more routine biotechnological approaches. For instance, utilizing manufactured genomics it is conceivable to outline and amass chromosomes, qualities and quality pathways, and even entire genomes.

Related Conferences:

2nd International Conference on Molecular Biology , London, UK , June 22-24, 2017; 3rd World Bio Summit & Expo, Abu Dhabi, UAE, June 19-21, 2017; 5th International Conference on Integrative Biology, London, UK,June 19-21, 2017; 2nd World Congress on Human Genetics, Chicago, USA, July 24-26, 2017; 9th International Conference on Genomics and Pharmacogenomics, Chicago, USA, July 13-14, 2017.

 

Synthetic Gene Network

Plan and development of Synthetic gene network from secluded segments is a noteworthy objective of engineered science. Nonetheless, the development of quality systems with unsurprising capacities remains hampered by an absence of suitable segments and the way that amassed arranges regularly require broad, iterative retrofitting to function as proposed. Propels in the improvement of atomic devices for the inducible control of interpretation, interpretation, and protein debasement are the premise for the quickly developing configuration and development of engineered quality systems in mammalian cells. Nonetheless, progresses in manufactured science have been constrained by an absence of interoperable parts, strategies for powerfully testing organic frameworks and systems for the solid development and operation of mind boggling, higher-request systems. As these difficulties are tended to, manufactured scholars will have the capacity to develop helpful cutting edge engineered quality systems with certifiable applications in prescription, biotechnology, bioremediation and bioenergy. Artificial gene synthesis amalgamation is a strategy in Synthetic Biology that is utilized to make artificial genes in the research facilities.

Related Conferences:

5th International Conference on Integrative Biology June 19-21, 2017 London, UK; International Conference on Genetic Counseling and Genomic Medicine, December 07-08, 2016 Madrid, Spain; International Conference on Clinical and Medical Genetics December 01-02, 2016 Atlanta, USA; 9th International Conference on Genomics and Pharmacogenomics July 13-14, 2017 Chicago, USA.

 

Gene synthesis

Gene synthesis is a strategy in synthetic biology that is utilized to make create artificial genes in the research center. Currently based on solid-phase DNA synthesis, it contrasts from molecular cloning and polymerase chain reaction (PCR) in that the client does not need in the first place prior DNA sequences. Accordingly, it is conceivable to make a totally synthetic double-stranded DNA molecule with no obvious cutoff points on either nucleotide sequence or size. The technique has been utilized to create utilitarian bacterial or yeast chromosomes containing around one million base sets. Late research likewise proposes the likelihood of making novel nucleobase pairs notwithstanding the two base pairs in nature, which could incredibly extend the likelihood of growing the genetic code. Gene editing or genome editing with built nucleases (GEEN) is a sort of genetic engineering in which DNA is inserted, deleted or replaced in the genome of an organism utilizing engineered nucleases, or "molecular scissors." These nucleases create site-specific double-strand breaks (DSBs) at craved areas in the genome. The induced double strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), bringing about targeted mutations. There are at present four groups of engineered nucleases being utilized: Meganucleases, Zinc finger nucleases (ZFNs), Transcription Activator-Like Effector-based Nucleases (TALENs), and the CRISPR-Cas System.

Related Conferences:

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell ResearchOrlando, USA, March 20-22, 2017; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017; 2nd International Conference on Genetic Counselling and Genomic Medicine , Beijing, China, July 10-12, 2017; International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017.

 

Structural Biology

Structural biology is a branch of molecular biology, biochemistry, and biophysics concerned with the molecular structure of biological macromolecules, especially proteins and nucleic acids, how they secure the structures they have, and how modifications in their structures influence their capacity. This subject is of incredible enthusiasm to researcher since macromolecules complete the vast majority of the elements of cells, and on the grounds that it is just by curling into particular three-dimensional shapes that they can perform these functions. This engineering, the "tertiary structure" of molecule, depends complicatedly on the primary structures.

Relevant Conferences:

2nd International Conference on Molecular Biology , London, UK , June 22-24, 2017; 3rd World Bio Summit & Expo, Abu Dhabi, UAE, June 19-21, 2017; 5th International Conference on Integrative Biology, London, UK,June 19-21, 2017; 2nd World Congress on Human Genetics, Chicago, USA, July 24-26, 2017; 9th International Conference on Genomics and Pharmacogenomics, Chicago, USA, July 13-14, 2017.

 

Integrative Biology

As name "Integrative Biology" reflects conviction that the investigation of biological systems is best drawn nearer by fusing numerous points of view. We unite assorted qualities of controls that supplement each other to disentangle the complexity of biology. The idea incorporates anatomy, physiology, cell and stem cell biology, molecular biology, developmental biology, biochemistry and biophysics. We work with animals, plants and microorganisms and our exploration traverses the levels of the organic chain of command from molecules to ecosystems. Our expansive scope of mastery incorporates: geneticists, paleontologists, physiologists, behaviorists, systematists, morphologists, microbiologists, bioinformatician, evolutionary biologists, ecologists, biophysicists and biotechnologists.

Relevant Conferences:

7th International Conference on Plant Genomics, Bangkok, Thailand, July 03-05, 2017; 15th Euro BiotechnologyCongress, Valencia, Spain, June 05-07, 2017; International Conference on Integrative Medicine & Nutrition,Dubai, UAE, May11-13, 2017; 14th Asia-Pacific Biotech Congress, April 10-12, 2017; Beijing, China,15thBiotechnology Congress, Baltimore, USA, June 22-23, 2017.

 

Protein Engineering

Protein engineering is the procedure of creating helpful or profitable proteins. It is a youthful control, with much research occurring into the comprehension of protein folding and acknowledgment for  protein design principles. There are two general systems for protein engineering, rational protein design and directed evolution. These systems are not fundamentally unrelated; specialists will frequently apply both. Later on, more itemized learning of protein structure and capacity, and also headways in high-throughput innovation, might incredibly grow the abilities of protein engineering. In the long run, even unnatural amino acids might be incorporated, because of another strategy that permits the consideration of novel amino acids in the genetic code.

Relevant Conferences

5th International Conference and Exhibition on Cell and Gene Therapy, Madrid, Spain, Mar 2-3, 2017; International Conference on Cell Signalling and Cancer Therapy, Paris, France, Aug 20-22, 2017;  7th Annual Conference on Stem Celland Regenerative Medicine, Paris, France, Aug 04-05, 2016; 3rd International Conference & Exhibition on Tissue Preservation and Bio banking, Baltimore, USA,June 29-30, 2017.

 

Industrial Systems and Synthetic Biology

Industrial Systems and Synthetic Biology is a standout amongst the most encouraging new ways to deal with contamination counteractive action, asset protection, and cost lessening. It is frequently alluded to as the third wave in biotechnology. On the off chance that created to its maximum capacity, modern biotechnology might largely affect the world than human services and agriculture biotechnology. It offers organizations an approach to diminish costs and make new markets while securing the earth. Additionally, since a hefty portion of its items don't require the long audit times that medication items must experience, it's a speedier, less demanding pathway to the business sector. The utilization of Industrial Systems and Synthetic Biology to modern procedures is changing how we make items as well as giving us new items that couldn't be envisioned a couple of years back. Since Industrial Systems and Synthetic Biology is so new, its advantages are still not surely understood or comprehended by industry, policymakers, or customers.

Relevant Conferences

2nd Biotechnology World Convention, London, UK, May 25-27, 2017;  International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017; 9th International Conference on Cancer Genomics, Chicago, USA, May 29-31, 2017; 6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orlando, USA,March 20-22, 2017.

 

Biotechnology Advances

Biotechnology advances is the utilization of systems and organisms to create or make product, or any innovative application that uses biological, living organism’s forms or derivatives thereof, to make or alter products or procedures for particular use. Depending on the instruments and applications, it regularly covers with the (related) fields of bioengineering, biomedical building, biomanufacturing, and so forth.

Relevant Conferences:

15th World Congress on Biotechnology and Biotech Industries Meet ,Rome, Italy, March 20-21, 2017 2nd International Conference on Genetic Counselling and Genomic Medicine ,Beijing, China, July 10-12, 2017;  International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017; 15th Euro Biotechnology Congress, Valencia, Spain, June 05-07, 2017; International Conference on Integrative Medicine & Nutrition, Dubai, UAE, May11-13, 2017.

 

Metabolomics

Metabolomics is the experimental investigation of concoction procedures including metabolites. In particular, metabolomics is the deliberate investigation of the exceptional substance fingerprints that particular cell forms desert, the investigation of their little molecules metabolite profiles. The metabolome speaks to the accumulation of all metabolites in a biological cell, tissue, organ or living being, which are the end products of cell processes. mRNA quality expression data and proteomic examinations uncover the set of gene products being created in the cell, data that speaks to one part of cell function. On the other hand, metabolic profiling can give an immediate depiction of the physiology of that cell. One of the difficulties of system biology and functional genomics is to integrate proteomic, transcriptomic, and metabolomic data to give a superior comprehension of cell biology.

Relevant Conferences:

5th International Conference and Exhibition on Cell and Gene Therapy, MadridSpain, Mar 2-3, 2017; International Conference on Cell Signalling and Cancer Therapy,Paris, France, Aug 20-22, 2017; 2ndBiotechnology World Convention, London, UK, May 25-27, 2017; International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017; 9th International Conference on Cancer Genomics, Chicago, USA, May 29-31, 2017.

 

Biophysics

Biophysics covers the natural association, from the atomic level to entire life forms level in a biological processes. It depicts how creatures get sustenance, imparting, detecting nature, and repeating. Biophysical research requires some crucial standards from natural chemistry, nanotechnology, bioengineering, computational science and frameworks science.

Related Conferences:

International Conference on Integrative Medicine & Nutrition, Dubai, UAE, May11-13, 2017; International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017; International Conference on Cell Signalling and Cancer Therapy, Paris, France,Aug 20-22, 2017;

 

Bio-Sensors and Bio-Electronics

A biosensor is an analytical device, used for the detection of an analyte,that combines a biological component with a physicochemical detector. Electrochemical biosensors are normally based on enzymatic catalysis of a reaction that produces or consumes electrons (such enzymes are rightly called redox enzymes). The sensor substrate usually contains three electrodes; a reference electrode, a working electrode and a counter electrode. Amperometric biosensors function by the production of a current when a potential is applied between two electrodes. They generally have response times, dynamic ranges and sensitivities similar to the potentiometric biosensors. The potentiometric biosensor, (potential produced at zero current) gives a logarithmic response with a high dynamic range. Such biosensors are often made by screen printing the electrode patterns on a plastic substrate, coated with a conducting polymer and then some protein (enzyme or antibody) is attached. They have only two electrodes and are extremely sensitive and robust. A microbial biosensor is an analytical device which integrates microorganism(s) with a physical transducer to generate a measurable signal proportional to the concentration of analytes.

Related Conferences:

15th World Congress on Biotechnology and Biotech Industries Meet ,Rome, Italy, March 20-21, 2017;  6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orlando, USA, March 20-22, 2017;  14th Asia-Pacific Biotech Congress, Beijing, China, April 10-12, 2017;  5th International Conference on Integrative Biology, London, UK, June 19-21, 2017.

 

Next Generation Sequencing

Next-generation sequencing alludes to non-Sanger-based high-throughput DNA sequencing technologies. Millions or billions of DNA strands can be sequenced in parallel, yielding considerably more throughput and minimizing the requirement for the fragment cloning techniques that are frequently utilized as a part of Sanger sequencing of genomes. DNA sequencing industry is sectioned into instruments and consumables, administrations, and workflow products.

Relevant Conferences:

5th International Conference and Exhibition on Cell and Gene Therapy,Madrid, Spain, Mar 2-3, 2017;  International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017;  9th International Conference on Cancer Genomics, Chicago, USA, May 29-31, 2017;  14th Asia-Pacific Biotech Congress, Beijing, China, April 10-12, 2017.

 

Computational Systems Biology

Computational biology includes hypothetical strategies, mathematical and computational reenactment procedures to investigation of biological and social frameworks. The field is incorporates establishment in computer science, animation, biochemistry, biophysics, molecular biology, genetics, genomics, ecology, evolution, anatomy, neuroscience and visualization computational biology. Here and there alluded to as bioinformatics, is the investigation of utilizing natural information to create calculations and relations among different organic frameworks. Preceding the approach of computational biology, researcher were not able have entry to a lot of data. Systems Biology concentrates on analytical and computational models that are unequivocally bolstered and propelled by genuine biological systems and that incorporate current exact learning.

Relevant Conferences:

2nd World Congress on Human Genetics, Chicago, USA, July 24-26, 2017; 2nd International Conference on Genetic Counselling and Genomic Medicine ,Beijing, China, July 10-12, 2017;  International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017; 2nd International Conference on Molecular Biology ,London, UK, June 22-24, 2017; 15th Biotechnology Congress, Baltimore, USA, June 22-23, 2017.

 

Pharmaceutical Biology

The pharmaceutical biology is a gathering of interdisciplinary zones of study concerned with the desigin, activity, delivery, and disposition of drugs. Applying the  knowledge from chemistry such as inorganic, physical, biochemical and analytical from one end and from another end of Biology is dealing with life structures, physiology, organic chemistry, cell science, and molecular biology, epidemiology, statistics, chemometrics, mathematics, physics, and chemical engineering. As new disclosures progress and amplify the pharmaceutical biology, subspecialties keep on being added to this list. These shared fundamental concepts further to the understanding of their applicability to all aspects of pharmaceutical research and drug therapy.

Related Conferences:

7th Annual Conference on Stem Cell and Regenerative Medicine, Paris, France, Aug 04-05, 2016;  2ndBiotechnology World Convention, LONDON, UK, May 25-27, 2017; International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017; 9th International Conference on Cancer Genomics, Chicago, USA, May 29-31, 2017;  3rd International Conference on Synthetic Biology, Munich, Germany, July 20-21, 2017.





Past Conference Report

Systems and Synthetic Biology 2016

Past Conference Report

Conference Series LLC takes a great pride in announcing the commencement of 2nd International Conference on Systems and Synthetic Biology which was held in London, United Kingdom, during August 18-20, 2016.

Systems and Synthetic Biology -2016 has received a benevolent response from all over the world. This has been conducted with the aim and the categorical intent of promoting the developments of new perceptions and ideas for exploring the high level of knowledge reached by scientific community. The extremely illustrious conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries around the world. 

The conference aimed a parallel rail with theme “Systems and Synthetic Biology- Accomplish Impossible to Possible”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like:

Structural Biology

Integrative Biology

Protein Engineering

Industrial Systems and Synthetic Biology

Biotechnology Advances

Metabolomics

Synthetic Genomics

Synthetic Gene Network

Gene Synthesis

Biophysics

Bio-Sensors and Bio-Electronics

Next Generation Sequencing

Computational Systems Biology

Pharmaceutical Biology

The three days event implanted a firm relation of upcoming strategies in the field of Systems and Synthetic Biology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The Organizing Committee would like to thank the moderator Dr. Betty Lee, United States Department of Commerce, USA for her contribution which resulted in smooth functioning of the conference.

We are thankful to our Honourable guests for their generous support and suggestions.

  • Richard J Naftalin, King’s College London, UK
  • Roberto Mazzoli, University of Torino, Italy
  • Guido Krupp, AmpTec GmbH, Germany

A special session was organized by Paul Lomax (TTP Labtech, UK) his lecture on “Automation at the heart of synthetic biology and Dr. Betty Lee (United States Department of Commerce, USA) her lecture on “Biosecurity and how export controls impact the life sciences”.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Systems and Synthetic Biology-2016. The highlights of the conference were the keynote forum by prominent scientists, of which the following topics were highlighted:

  • Synthetic mRNAs as optimized tools for stem cell generation and for manipulating cellular phenotypes: Guido Krupp, AmpTec GmbH, Germany
  • Enhancing the synthetic IQ of CAR T-cells: Michael Jensen, Seattle Children’s Research Institute, USA
  • A computer model simulating human glucose absorption and metabolism in health and metabolic disease states: Richard J Naftalin, King’s College London, UK

These are some of the few speakers who gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Various sessions were chaired and co-chaired by: Guido Krupp, AmpTec GmbH, Germany; Roberto Mazzoli, University of Torino, Italy; Anthony C Forster, Uppsala University, Sweden; Martin Falk, Czech Academy of Sciences, Czech Republic; Richard J Naftalin, King’s College London, UK.

We congratulate Dr. Ingy Hashad from German University in Cairo, Egypt for winning the Young Research Forum award.

Conference Series LLC has taken the privilege of felicitating Systems and Synthetic Biology-2016 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this conference.

The esteemed guests, keynote speakers and researchers shared their innovative research and vast experience through their informative presentations at the podium of Systems and Synthetic Biology. We are glad to inform that all accepted abstracts for the conference have been published in Journal of Current Synthetic and System Biology-Open Access as a special issue.

Conference Series LLC offers its heartfelt appreciation to the exhibitors TTP Labtech and Forte Bio who supported the conference in every aspect for the awe-inspiring exhibition at the venue. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

We are also obliged to various experts, company representatives and other eminent scientists who supported the conference by facilitating the discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance. With the unique feedback from the conference, Conference Series LLC would like to proudly announce the commencement of the "3rd International Conference on Systems and Synthetic Biology" to be organized during July 20-21, 2017 at Munich, Germany.

Mark your calendars for the upcoming extravaganza; we are hoping to see you soon!

 For More details: http://syntheticbiology.conferenceseries.com/


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date July 20-21, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Media Partners

Conferenceseries Destinations